Profil bibliographique

Iwona Danielewicz

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

40Publications signalées

754Citations signalées

4Affiliations récentes

Institutions déclarées

University of Business and Administration in Gdynia Gdynia Maritime University Provincial Polyclinical Hospital in Toruń Pomeranian Medical University

Domaines associés

Advanced Breast Cancer TherapiesCancer Treatment and PharmacologyBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer Immunotherapy and Biomarkers

Publications récentes

Accès ouvert 2026 articleOpenAlex

Clinical outcomes of sacituzumab govitecan in older patients with metastatic triple-negative breast cancer: a multinational real-world study

Aleksandra Konieczna, Małgorzata Pieniążek, Justyna Żubrowska, Anna Polakiewicz-Gilowska et autres

0 citationsThe Oncologist

Accès ouvert 2026 articleOpenAlex

Association of PD-L1 combined positive score with disease control and response kinetics with first-line pembrolizumab-based therapy in metastatic triple-negative breast cancer: results from routine clinical practice in Poland

Małgorzata Pieniążek, K Swiderska, Aleksandra Konieczna, Iwona Danielewicz et autres

0 citationsClinical & Translational Oncology

2026 articleOpenAlex

Real-world survival outcomes with pembrolizumab plus chemotherapy in advanced triple-negative breast cancer: Multicenter evidence from Poland, the Czech Republic, and Slovakia.

Miroslawa Puskulluoglu, Joanna Kiszka, Aleksandra Konieczna, Miloš Holánek et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Baseline inflammatory indexes and prognosis for progression-free survival in first-line pembrolizumab plus chemotherapy for PD-L1-positive advanced triple-negative breast cancer: A Polish multicenter cohort study.

Małgorzata Pieniążek, Karolina Winsko-Szczęsnowicz, Aleksandra Konieczna, Iwona Danielewicz et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex

Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohort

Karolina Winsko-Szczęsnowicz, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, Marcin Kubeczko et autres

0 citationsClinical & Translational Oncology

Accès ouvert 2026 articleOpenAlex

Effectiveness of sacituzumab govitecan in metastatic triple-negative breast cancer: a real-world retrospective cohort study from Central Europe

Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, Justyna Żubrowska, Lenka Rušinová et autres

1 citationThe Oncologist

Accès ouvert 2026 articleOpenAlex

First real-world experience with first-line pembrolizumab and chemotherapy treatment for advanced triple-negative breast cancer in Poland: safety analysis and first survival outcomes from a multicenter cohort

Małgorzata Pieniążek, Aleksandra Konieczna, K Swiderska, Iwona Danielewicz et autres

0 citationsOncology in Clinical Practice

Accès ouvert 2026 articleOpenAlex

Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort study

Justyna Żubrowska, Malgorzata Anielka Pieniazek, Anna Polakiewicz-Gilowska, Lenka Rušinová et autres

0 citationsThe Breast

Accès ouvert 2026 articleOpenAlex

Real-world outcomes of sacituzumab govitecan in patients with pretreated triple-negative breast cancer and brain metastases: data from CEBCC-102 study

Justyna Żubrowska, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, Iveta Kolářová et autres

0 citationsJournal of Neuro-Oncology

Accès ouvert 2026 articleOpenAlex

Impact of Germline BRCA1/2 Mutations on Clinical Outcomes in Metastatic Triple-Negative Breast Cancer Patients Treated with Sacituzumab Govitecan—An International CEBCC Study from Poland, the Czech Republic and Slovakia

Renata Pacholczak-Madej, Mirosława Püsküllüoğlu, Anna Polakiewicz-Gilowska, Małgorzata Pieniążek et autres

0 citationsOncology Research Featuring Preclinical and Clinical Cancer Therapeutics

Accès ouvert 2025 articleOpenAlex

Efficacy and safety of sacituzumab govitecan in patients with metastatic metaplastic triple-negative breast cancer: a multinational retrospective case series from CEBCC-102 study

Justyna Żubrowska, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, Miroslava Malejčíková et autres

1 citationBreast Cancer Research and Treatment

Accès ouvert 2025 articleOpenAlex

Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2− advanced breast cancer: A multicenter retrospective study

Renata Duchnowska, Katarzyna Soter, Katarzyna Pogoda, Jolanta Smok-Kalwat et autres

7 citationsThe Breast

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.